The Enterprise Value as of June 2026 (TTM) for Relay Therapeutics, Inc. (RLAY) is 2.42B

According to Relay Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 2.42B. This represents a change of 121.37% compared to the average of 1.09B of the last 4 quarters.

Relay Therapeutics, Inc. (RLAY) Historical Enterprise Value (quarterly & annually)

How has RLAY Enterprise Value performed in the past?

The mean historical Enterprise Value of Relay Therapeutics, Inc. over the last ten years is 1.21B. The current 2.42B Enterprise Value has changed 19.87% with respect to the historical average. Over the past ten years (40 quarters), RLAY's Enterprise Value was at its highest in in the December 2020 quarter at 3.31B. The Enterprise Value was at its lowest in in the June 2019 quarter at 0.

Relay Therapeutics, Inc. (RLAY) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Relay Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Relay Therapeutics, Inc. (RLAY) Average Enterprise Value

How has RLAY Enterprise Value performed in the past?

The current Enterprise Value of Relay Therapeutics, Inc. (RLAY) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Relay Therapeutics, Inc. (RLAY) Enterprise Value vs. Peers

How is RLAY’s Enterprise Value compared to its peers?

Relay Therapeutics, Inc.’s Enterprise Value is greater than Syndax Pharmaceuticals, Inc. (1.83B), greater than ORIC Pharmaceuticals, Inc. (799.69M), greater than Amylyx Pharmaceuticals, Inc. (989.29M), greater than Inhibrx Biosciences, Inc. (1.20B), greater than Upstream Bio, Inc. (236.35M), greater than Nektar Therapeutics (1.17B), greater than CureVac N.V. (525.74M), greater than Immatics N.V. (800.42M), greater than Sana Biotechnology, Inc. (737.35M), greater than Zenas BioPharma, Inc. (735.43M),

Build a custom stock screener for Relay Therapeutics, Inc. (RLAY) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Relay Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Relay Therapeutics, Inc. (RLAY) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Relay Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.